Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Dr. Bardwell on Cancer-Related Variables and Depression

      October 25, 2011
      By Wayne A. Bardwell, PhD, MBA
      Article

      Dr. Wayne Bardwell from UCSD Cancer Center on Cancer-Related Variables and Depression

      Wayne A. Bardwell, PhD, MBA, Associate Professor of Psychiatry, director, Patient & Family Support Service, Doris Howell Service Moores, University of California, San Diego, Cancer Center, discusses his research into the connection between objective cancer-related variables and depression symptoms in breast cancer patients.

      The depression symptoms analysis was completed as part of the Women's Healthy Eating and Living (WHEL) study that examined the effects of dietary intervention on 3088 women following the completion of treatment for early-stage breast cancer. Data was collected before and after the introduction of the dietary intervention and tested against 27 potential risk factors that predict depression. Each factor was measured using various instruments that were selected based on social cognitive theory.

      The results of the study were counterintuitive. Objective cancer-related factors, such as intensity of treatment and length of time from diagnosis, as well as health-related factors, such as side effects and physical activity, did not play a role in developing depression. The lead cause of depression stemmed from psychosocial factors such as insomnia, support groups, and being comfortable expressing feelings. These psychosocial issues are very similar to the cause of depression in the general population.

      The trial concluded that depressive symptoms are not associated with objective cancer-related factors but are connected to subjective psychosocial variables.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with blond hair wearing a green shirt in front of a blue background
      Image of a woman with blonde hair wearing a white and black blazer
      2 experts are featured in this series.
      Related Content

      Icon of a breast with various clinicians using medical equipment

      Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events

      Bridget Hoyt
      August 23rd 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      August 23rd 2025
      Podcast

      Image of a breast with tumor

      PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert

      Bridget Hoyt
      August 23rd 2025
      Article

      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      August 23rd 2025
      Podcast

      graphic of a person with breast tumors

      JSKN003 Shows Activity in Heavily Pretreated HER2+ Breast Cancer

      Chris Ryan
      August 23rd 2025
      Article

      Graphic of a person with a breast tumor

      Awareness of Actionable Mutations Guides mBC Treatment Post-Endocrine

      Bridget Hoyt
      August 23rd 2025
      Article
      Related Content

      Icon of a breast with various clinicians using medical equipment

      Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events

      Bridget Hoyt
      August 23rd 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      August 23rd 2025
      Podcast

      Image of a breast with tumor

      PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert

      Bridget Hoyt
      August 23rd 2025
      Article

      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      August 23rd 2025
      Podcast

      graphic of a person with breast tumors

      JSKN003 Shows Activity in Heavily Pretreated HER2+ Breast Cancer

      Chris Ryan
      August 23rd 2025
      Article

      Graphic of a person with a breast tumor

      Awareness of Actionable Mutations Guides mBC Treatment Post-Endocrine

      Bridget Hoyt
      August 23rd 2025
      Article

      Latest Conference Coverage

      How Nurses Can Assess and Manage Talquetamab Toxicities

      Transformative Care: A Nurse Guide to Novel Therapies in Blood Cancers

      Personalized Cancer Vaccines: Watching For Immune-Related, Vaccine AEs

      Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.